Prevalence of Use and the Risk of Adverse Effects Associated with Complementary and Alternative Medicine in a Cohort of Patients Receiving Warfarin

Abstract

Spanish

French

Background

The use of complementary and alternative medicine (CAM), including orally administered herbals, botanicals, vitamins, and supplements, may pose a risk to patients on warfarin therapy.

Objective

To estimate the prevalence of CAM use among patients taking warfarin and evaluate the impact of CAM exposure on the risk of warfarin-related adverse effects.

Methods

A survey was administered to hospital inpatients and clinic outpatients on drug exposure (including CAM) over the previous month, self-reported bleeding events, use of alcohol and vitamin K–rich foods, and medical conditions. Prescription medication use was verified, and laboratory records were checked for out-of-range international normalized ratios (INRs) (defined as INR >4 or <2). The use of CAM, including products with reported or theoretical interactions with warfarin, was compared between patients with and without self-reported bleeding or out-of-range INR.

Results

Among the 314 patients who completed the survey, 44.3% reported using CAM at least weekly. Potentially interacting CAM was used by 34.1% of all patients, or 18.2% if vitamin E was excluded as an interacting CAM. Vitamin E was used by 24.2% of all patients and 71.0% of those who used potentially interacting CAM. There was no significant difference in CAM use or consumption of vitamin K–rich foods between patients with and without INRs greater than 4 or for patients with and without INRs less than 2.

Conclusions

The use of potentially interacting CAM in this cohort was higher than the use previously reported among patients on warfarin therapy. However, exposure to CAM was not associated with an increase in the risk of self-reported bleeding or out-of-range INR.

Keywords

complementary and alternative medicine herb–drug interactions international normalized ratio warfarin

Get full access to this article

View all access options for this article.

References

Ansell

Hirsh

Poller

Bussey

Jacobson

Hylek

. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th ed). Chest 2008;133: 160S–98S. DOI 10.1378/chest.08-0670

Shalansky

Lynd

Richardson

Ingaszewski

Kerr

. Risk of warfarin-related bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: a longitudinal analysis. Pharmacotherapy 2007;27:1237–47. DOI 10.1592/phco.27.9.1237

Hylek

Skates

Sheehan

Singer

. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 1996;335:540–6. DOI 10.1056/NEJM199608223350802

Wittkowsky

Devine

. Frequency and causes of overanticoagulation and underanticoagulation in patients treated with warfarin. Pharmacotherapy 2004;24:1311–6. DOI 10.1592/phco.24.14.1311.43144

Ramsay

Kenny

Davies

Patel

. Complementary and alternative medicine use among patients starting warfarin. Br J Haematol 2005;130:777–80. DOI 10.1111/j.1365-2141.2005.05689.x

Wittkowsky

. Drug interactions update: drugs, herbs, and oral anticoagulation. J Thromb Thrombolysis 2001;12:67–71.

National Center for Complementary and Alternative Medicine, National Institutes of Health. What is CAM? NCCAM publication no. D347, 2007. http://nccam.nih.gov/health/whatiscam/ (accessed 2008 Sep 22).

Tindle

Davis

Phillips

Eisenberg

. Trends in use of complementary and alternative medicine by US adults: 1997–2002. Altern Ther Health Med 2005;11:42–9.

Qato

Alexander

Conti

Johnson

Schumm

Lindau

. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 2008;300:2867–78. DOI 10.1001/jama.2008.892

10.

Elmer

Lafferty

Tyree

Lind

. Potential interactions between complementary/alternative products and conventional medicines in a Medicare population. Ann Pharmacother 2007;41:1617–24. Epub 4 Sept 2007. DOI 10.1345/aph.1K221

11.

Liu

Turner

Lin

. Use of alternative medicine by patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2000;120:335–41. DOI 10.1067/mtc.2000.107339

12.

Bolling

. The use of complementary and alternative therapies among middle-aged and older cardiac patients. Am J Med Qual 2002;17:21–7. DOI 10.1177/106286060201700105

13.

Wood

Stewart

Merry

Johnstone

Cox

. Use of complementary and alternative medical therapies in patients with cardiovascular disease. Am Heart J 2003;145:806–12. DOI 10.1016/S0002-8703(03)00084-X

14.

Barraco

Valencia

Riba

Nareddy

Draus

Schwartz

. Complementary and alternative medicine (CAM) use patterns and disclosure to physicians in acute coronary syndromes patients. Complement Ther Med 2005;13:34–40. DOI 10.1016/j.ctim.2005.02.003

15.

Zick

Blume

Aaronson

. The prevalence and pattern of complementary and alternative supplement use in individuals with chronic heart failure. J Card Fail 2005;11:586–9. DOI 10.1016/j.cardfail.2005.06.427

16.

Yeh

Davis

Phillips

. Use of complementary therapies in patients with cardiovascular disease. Am J Cardiol 2006;98:673–80. DOI 10.1016/j.amjcard.2006.03.051

17.

Krasuski

Michaelis

Eckart

. The cardiovascular patient's perceptions of complementary and alternative medicine. Clin Cardiol 2006;29:161–4. DOI 10.1002/clc.4960290407

18.

Holbrook

Pereira

Labiris

. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med 2005;165:1095–106. DOI 10.1001/archinte.165.10.1095

19.

Pharand

Ackman

Jackevicius

Paradiso-Hardy

Pearson

, Canadian Cardiovascular Pharmacists Network. Use of OTC and herbal products in patients with cardiovascular disease. Ann Pharmacother 2003;37:899–904. DOI 10.1345/aph.1C163

20.

Miller

. Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 1998;158:2200–11. DOI 10.1001/archinte.158.20.2200

21.

Klepser

. Unsafe and potentially safe herbal therapies. Am J Health Syst Pharm 1999;56:125–38.

22.

Fugh-Berman

. Herb–drug interactions. Lancet 2000;355:134–8.

23.

Boullata

Nace

. Safety issues with herbal medicine. Pharmacotherapy 2000;20:257–69. DOI 10.1592/phco.20.4.257.34886

24.

Coxeter

McLachlan

Duke

Roufogalis

. Herb–drug interactions: an evidence based approach. Curr Med Chem 2004;11:1513–25.

25.

Fihn

McDonell

Martin

. Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group. Ann Intern Med 1993;118:511–20.

26.

Hylek

Singer

. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 1994;120:897–902.

27.

Zuckerman

Steinberger

Ryder

Haines

. Herbal product use among anticoagulation clinic patients. Am J Health Syst Pharm 2002;59:379–80.

28.

Smith

Ernst

PaulEwings

Myers

Smith

. Coingestion of herbal medicines and warfarin. Br J Gen Pract 2004;54:439–41.

29.

Wong

Cheng

Chan

. Use of herbal medicines by patients receiving warfarin. Drug Saf 2003;26:585–8. DOI 10.2165/00002018-200326080-00004

30.

Izzo

Di Carlo

Borrelli

Ernst

. Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction. Int J Cardiol 2005;98:1–14. DOI 10.1016/j.ijcard.2003.06.039

31.

Wolsko

Solondz

Phillips

Schachter

Eisenberg

. Lack of herbal supplement characterization in published randomized controlled trials. Am J Med 2005;118:1087–93. DOI 10.1016/j.amjmed.2005.01.076

32.

Gardiner

Graham

Legedza

Eisenberg

Phillips

. Factors associated with dietary supplement use among prescription medication users. Arch Intern Med 2006;166:1968–74. DOI 10.1001/archinte.166.18.1968

33.

Eisenberg

Kessler

Van Rompay

. Perceptions about complementary therapies relative to conventional therapies among adults who use both: results from a national survey. Ann Intern Med 2001;135:344–51.

34.

Cohen

Pan

. Complementary and alternative medicine (CAM) use by older adults: a comparison of self-report and physician chart documentation. J Gerontol A Biol Sci Med Sci 2002;57: M223–7.

35.

Giveon

Liberman

Klang

Kahan

. A survey of primary care physicians' perceptions of their patients' use of complementary medicine. Complement Ther Med 2003;11:254–60. DOI 10.1016/S0965-2299(03)00114-6

36.

Brown

Barner

Shah

. Community pharmacists' actions when patients use complementary and alternative therapies with medications. J Am Pharm Assoc (Wash DC) 2005;45:41–7. DOI 10.1331/1544345052843011

37.

Kwan

Hirschkorn

Boon

. U.S. and Canadian pharmacists' attitudes, knowledge, and professional practice behaviors toward dietary supplements: a systematic review. BMC Complement Altern Med 2006;6:31. DOI 10.1186/1472-6882-6-31